MATERIAL SAFETY DATA SHEET
BAYER CROPSCIENCE LP
P.O. Box 12014
2 T.W. Alexander Drive
Research Triangle Park, NC 27709
For Medical and Transportation Emergencies Only:
Call 24 hours a day 1-800-334-7577
For Product Use Information: Call 1-866-99BAYER (1-866-992-2937)
-------------------------------------------------------------------------------
1. CHEMICAL PRODUCT IDENTIFICATION:
-------------------------------------------------------------------------------
PRODUCT NAME........: AZTEC 2.1% G
PRODUCT CODE........: 11612
CHEMICAL FAMILY.....: Organophosphorous & Pyrethroid Insecticides
CHEMICAL NAME.......: 0-(2-(1,1-Dimethylethyl)-5-pyrimidinyl) 0-ethyl
0-(1-methylethyl) phosphorothioate &
Cyano(4-fluoro-3-phenoxyphenyl)methyl 3-(2,2-
dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate
SYNONYMS............: BAY MAT 7484 (tebupirimphos) & BAYTHROID (cyfluthrin)
FORMULA.............: C13 H23 N2 03 PS (tebupirimphos) & C22 H18 Cl2 F N 03
(cyfluthrin)
EPA Registration No.: 264-775
-------------------------------------------------------------------------------
2. COMPOSITION/INFORMATION ON INGREDIENTS:
-------------------------------------------------------------------------------
INGREDIENT NAME
/CAS NUMBER EXPOSURE LIMITS CONCENTRATION (%)
-------------------------------------------------------------------------------
-----------------------------------------
***** HAZARDOUS INGREDIENTS *****
-----------------------------------------
BAY MAT 7484 (tebupirimphos)
96182-53-5 OSHA : Not Established 2%
ACGIH: Not Established
----------------------------------------
BAYTHROID (cyfluthrin)
68359-37-5 OSHA : Not Established 0.1 %
ACGIH: Not Established
Product Code: 11612 MSDS Page 1
Approval date: 03/06/2003 Continued on next page
-------------------------------------------------------------------------------
3. HAZARDS IDENTIFICATION:
-------------------------------------------------------------------------------
*****************************************************************
* EMERGENCY OVERVIEW *
* *
* WARNING! Color: Off-white to grey; Form: Solid; Granules; *
* Harmful if inhaled; Harmful if absorbed through skin; Causes *
* eye irritation; May be fatal if swallowed. *
*****************************************************************
POTENTIAL HEALTH EFFECTS:
ROUTE(S) OF ENTRY..................: Inhalation; Skin Contact; Skin Absorption;
Eye Contact
HUMAN EFFECTS AND SYMPTOMS OF OVEREXPOSURE:
ACUTE EFFECTS OF EXPOSURE.....: Inhalation, dermal absorption or ingestion of
the organophosphate insecticide contained in this formulation may result in
systemic intoxication due to inhibition of the enzyme cholinesterase. The
sequence of development of systemic effects varies with the route of entry,
and the onset of symptoms may be delayed up to 12 hours. First symptoms of
poisoning may be nausea, increased salivation, lacrimation, blurred vision
and constricted pupils. Other symptoms of systemic poisoning include
vomiting, diarrhea, abdominal cramping, dizziness and sweating. After
inhalation, respiratory symptoms like tightness of chest, wheezing, and
laryngeal spasms, may be pronounced at first. If the poisoning is severe,
then symptoms of convulsions, low blood pressure, cardiac irregularities,
loss of reflexes and coma may occur. In extreme cases, death may occur due
to a combination of factors such as respiratory arrest, paralysis of
respiratory muscles or intense bronchoconstrictions. Complete symptomatic
recovery from sublethal poisoning usually occurs within one week once the
source of exposure is completely removed. Skin irritation may occur from
contact with the pyrethroid insecticide contained in this formulation, and
produce symptoms such as itching, skin reddening or rash. Paresthesia (a
tingling or burning sensation on the surface of the skin) may also result
from skin contact. This is a frequently reported symptom associated with
sufficient dermal exposure to synthetic pyrethroids and normally subsides
without treatment within 24 hours. The onset of these symptoms usually
occurs 2-12 hours after exposure. Mucous membrane irritation involving the
nose, throat and upper respiratory tract may occur from inhalation of dust
during end use of the product such as an application. Based on EPA
Toxicity Category criteria, this product is moderately toxic orally and
mildly toxic dermally. In addition, animal studies have shown that it can
cause moderate eye and skin irritation.
CHRONIC EFFECTS OF EXPOSURE...: Cholinesterase inhibition sometimes persists
for 2-6 weeks, thus repeated exposure to small amounts of this material may
result in an unexpected cholinesterase depression causing symptoms such as
malaise, weakness, and anorexia that resemble other illnesses such as
influenza. Exposure to a concentration that would not have produced
Product Code: 11612 MSDS Page 2
Approval date: 03/06/2003 Continued on next page
3. HAZARDS IDENTIFICATION (Continued)
---------------------------------------
symptoms in a person that was not previously exposed may produce severe
symptoms of cholinesterase inhibition in a previously exposed person.
CARCINOGENICITY...............: This product is not listed by NTP, IARC or
regulated as a carcinogen by OSHA.
MEDICAL CONDITIONS
AGGRAVATED BY EXPOSURE......: No specific medical conditions are known which
may be aggravated by exposure to the organophosphate insecticide contained
in this formulation; however, any disease, medication or prior exposure
which reduces normal cholinesterase activity may increase susceptibility to
the toxic effects of the active ingredient. As with any material which can
cause upper respiratory tract irritation, such as the pyrethroid
insecticide contained in this formulation, persons with a history of
asthma, emphysema, or hyperreactive airway disease, may be more susceptible
to overexposure.
-------------------------------------------------------------------------------
4. FIRST AID MEASURES:
-------------------------------------------------------------------------------
FIRST AID FOR EYES......: Hold eye open and rinse slowly and gently with water
for 15-20 minutes. Remove contact lenses, if present, after the first 5
minutes, then continue rinsing eye. Call a poison control center or doctor
for treatment advice.
FIRST AID FOR SKIN......: Take off contaminated clothing. Rinse skin
immediately with plenty of water for 15-20 minutes. Call a poison control
center or doctor for treatment advice.
FIRST AID FOR INHALATION: Move person to fresh air. If person is not
breathing, call 911 or an ambulance; then give artificial respiration,
preferably by mouth-to-mouth, if possible. Call a poison control center or
physician for further treatment advice.
FIRST AID FOR INGESTION.: Call poison control center or doctor immediately for
treatment advice. Have person sip a glass of water if able to swallow. Do
not induce vomiting unless told to do so by the poison control center or
doctor. Do not give anything to an unconscious person.
NOTE TO PHYSICIAN.......: This product contains tebupirimphos, a cholinesterase
inhibitor. Cholinesterase inhibition results in stimulation of the central
nervous system, the parasympathetic nervous system and the somatic motor
nerves. If symptoms of organophosphate poisoning are present, the
administration of atropine sulfate is indicated. Administer atropine
sulfate in large, therapeutic doses. In mild cases, start treatment by
giving 1-2 mg of atropine intravenously every 15 minutes until signs of
atropinization appear (dry mouth, flushing, and dilated pupils if pupils
were originally pinpoint). In severe cases, start treatment by giving 2-4
mg intravenously every 5-10 minutes until fully atropinized. Dosages for
children should be appropriately reduced. 2-PAM is also antidotal and may
be used in conjunction with atropine. Do not give morphine. Watch for
pulmonary edema which may develop in serious cases of poisoning even after
24 hours. At first sign of pulmonary edema, place patient in oxygen tent
Product Code: 11612 MSDS Page 3
Approval date: 03/06/2003 Continued on next page
4. FIRST AID MEASURES (Continued)
-----------------------------------
and treat symptomatically. This product also contains cyfluthin, a
synthetic pyrethroid. Published data indicate vitabin E acetate can
prevent and/or mitigate symptoms of paresthesia caused by synthetic
pyrethroids. In case of poisoning, it is requested that Bayer Crop
Science be notified. Call the emergency number on page 1.
-------------------------------------------------------------------------------
5. FIRE FIGHTING MEASURES:
-------------------------------------------------------------------------------
FLASH POINT.....................: Not Applicable
FLAMMABLE LIMITS:
UPPER EXPLOSIVE LIMIT (UEL)(%): Not applicable
LOWER EXPLOSIVE LIMIT (LEL)(%): Not applicable
EXTINGUISHING MEDIA.............: Water; Dry Chemical
SPECIAL FIRE FIGHTING PROCEDURES: Keep out of smoke. Cool exposed containers
with water spray. Fight fire from upwind position. Use self-contained
breathing equipment. Contain runoff to prevent entry into sewers or
waterways. Equipment or materials involved in pesticide fires may become
contaminated.
-------------------------------------------------------------------------------
6. ACCIDENTAL RELEASE MEASURES:
-------------------------------------------------------------------------------
SPILL OR LEAK PROCEDURES..........: Isolate area and keep unauthorized people
away. Do not walk through spilled material. Avoid breathing dusts and
skin contact. Avoid generating dust (a fine water spray mist, plastic film
cover, or floor sweeping compound may be used if necessary). Use
recommended protective equipment while carefully sweeping up spilled
material. Place in covered container for reuse or disposal. Scrub
contaminated area with detergent and bleach solution. Rinse with water.
Use dry absorbent material such as clay granules to absorb and collect wash
solution for proper disposal. Contaminated soil may have to be removed and
disposed of. Do not allow material to enter streams, sewers, or other
waterways.
-------------------------------------------------------------------------------
7. HANDLING AND STORAGE:
-------------------------------------------------------------------------------
STORAGE TEMPERATURE(MIN/MAX): None/30 day average not to exceed 100 F
SHELF LIFE..................: Time/temperature-dependent. Contact Bayer Crop
Science for additional information.
SPECIAL SENSITIVITY.........: Heat, Moisture
Product Code: 11612 MSDS Page 4
Approval date: 03/06/2003 Continued on next page
7. HANDLING AND STORAGE (Continued)
-------------------------------------
HANDLING/STORAGE PRECAUTIONS: Store in a cool, dry area designated specifically
for pesticides. Do not store near any materials intended for use or
consumption by humans or animals.
-------------------------------------------------------------------------------
8. PERSONAL PROTECTION:
-------------------------------------------------------------------------------
EYE PROTECTION REQUIREMENTS........: Goggles or glasses with side shields
should be used to prevent dust from getting into the eyes.
SKIN PROTECTION REQUIREMENTS.......: Avoid skin contact. Wear long sleeves and
trousers. Use chemical-resistant gloves.
VENTILATION REQUIREMENTS...........: Maintain exposure levels below the
exposure limits through the use of general and local exhaust ventilation.
RESPIRATOR REQUIREMENTS............: Under normal conditions of use,
respiratory protection is not needed; however, if use conditions lead to
excessive concentrations of airborne dust, use a NIOSH-approved particulate
respirator.
ADDITIONAL PROTECTIVE MEASURES.....: Clean water should be available for
washing in case of eye or skin contamination. Educate and train employees
in safe use of the product. Follow all label instructions. Launder
clothing separately after use. Wash thoroughly after handling.
-------------------------------------------------------------------------------
9. PHYSICAL AND CHEMICAL PROPERTIES:
-------------------------------------------------------------------------------
PHYSICAL FORM.............: Solid; Granules
COLOR.....................: Off-white to grey
ODOR......................: Not Noted
MOLECULAR WEIGHT..........: 318.4 for tebupirimphos; 434.3 for cyfluthrin
BOILING POINT.............: Not applicable
MELTING/FREEZING POINT....: Not applicable
SOLUBILITY IN WATER ......: 2 ppb for cyfluthrin; 5.5 ppm for tebupirimphos
SPECIFIC GRAVITY .........: Not Established
BULK DENSITY..............: 43-49 lb./cu. ft.
% VOLATILE BY VOLUME......: Not Established
VAPOR PRESSURE ...........: Not Established
VAPOR DENSITY ............: Not applicable (Air = 1)
-------------------------------------------------------------------------------
10. STABILITY AND REACTIVITY:
-------------------------------------------------------------------------------
STABILITY..................: This is a stable material.
HAZARDOUS POLYMERIZATION...: Will not occur.
INCOMPATIBILITIES..........: Strong oxidizers and bases; may react with
methanol.
Product Code: 11612 MSDS Page 5
Approval date: 03/06/2003 Continued on next page
10. STABILITY AND REACTIVITY (Continued)
------------------------------------------
INSTABILITY CONDITIONS.....: Not Noted
DECOMPOSITION PRODUCTS.....: Not established.
-------------------------------------------------------------------------------
11. TOXICOLOGICAL INFORMATION:
-------------------------------------------------------------------------------
Only acute studies have been performed on this product as formulated. The
non-acute information pertains to the active ingredients, cyfluthrin and
tebupirimphos.
ACUTE TOXICITY
ORAL LD50..........: Male Rat: 246 mg/kg -- Female Rat: 122 mg/kg
DERMAL LD50........: Male and Female Rabbit: >2000 mg/kg
INHALATION LC50....: 4 Hr. Exposure to Dust: Male and Female Rat: >1.15
mg/L (actual); 1 Hr. Exposure to Dust (extrapolated from 4 Hr. LC 50): Male
and Female Rat: >4.60 mg/L (actual)
EYE EFFECTS........: Rabbit: Moderate irritation to the iris and
conjunctiva was observed with all irritation clearing within 96 hours
post-treatment.
SKIN EFFECTS.......: Rabbit: Moderate irritation (erythema) was observed
with all irritation clearing within 96 hours post-treatment.
SENSITIZATION......: Guinea pig: Not a dermal sensitizer
SUBCHRONIC TOXICITY...: CYFLUTHRIN: In a 3 week dermal toxicity study,
cyfluthrin technical was administered to rats for 6 hours/day at dose levels
of 100, 340 or 1000 mg/kg. Animals received a total of 17-18 applications in
a period of 22-23 days. An additional control and high-dose group were
treated and maintained for 14-15 days following treatment so as to ascertain
the extent of recovery. Effects observed included reduced feed consumption,
red nasal discharge, urine stains, and findings at the dose site (scabbing,
crusty, discolored and raised zones). Histologically, epidermal and dermal
alterations in treated skin were observed in animals of the mid- and high-dose
groups. Similar, but slightly less severe microscopic alterations were also
observed in the high-dose recovery group. The overall NOEL was 100 mg/kg. In
a 13 week inhalation study, rats were exposed to cyfluthrin at aerosol
concentrations of 0.09, 0.71 or 4.51 mg/m3 for 6 hours/day, 5 days/week. The
NOEL was 0.09 mg/m3 based on reduced body weight gains. TEBUPIRIMPHOS: In a
dermal toxicity study, rabbits were treated with tebupirimphos at levels of
0.3, 1.0, or 3.0 mg/kg for 6 hours/day, 5 days/week for 3 weeks.
Cholinesterase inhibition occurred at 1.0 mg/kg and greater with cholinergic
symptoms observed at the high dose. The no-observable-effect-level (NOEL) was
0.3 mg/kg. When rats were exposed via inhalation to tebupirimphos at aerosol
concentrations of 0.16, 1.04 or 6.71 mg/m3 for 6 hours/day, 5 days/week for 4
weeks, the lowest-observable-effect-level (LOEL) was 1.04 mg/m3 based on
erythrocyte cholinesterse inhibition. The NOEL was 0.16 mg/m3.
CHRONIC TOXICITY......: CYFLUTHRIN: Cyfluthrin has been investigated in
chronic feeding studies using two different strains of rats. In each study,
cyfluthrin was administered for 2 years at dietary concentrations ranging from
50 to 450 ppm. Body weight gains were decreased at concentrations of 150 ppm
and greater. Changes in clinical chemistries occurred at 450 ppm. In one of
Product Code: 11612 MSDS Page 6
Approval date: 03/06/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
the studies, histopathology revealed a numerical increase in mammary gland
adenocarcinomas at 450 ppm. The finding was not statistically significant
when compared to the controls and is not considered to be compound-related.
In each study, the overall NOEL was 50 ppm based on decreased body weight
gains. In a 1 year feeding study, dogs were administered cyluthrin at dietary
concentrations of 50, 100 360 or 650 ppm. Beginning on week 8, the high-dose
was reduced to 500 ppm for the remainder of the study due to severe clinical
neurological symptoms. Body weights were decreased for animals of the
high-dose. Neurological findings (gait adnormalities and postural reaction
deficits) were observed at doses of 360 and greater. The NOEL was 100 ppm.
TEBUPIRIMPHOS: In a 1 year feeding study on dogs, tebupirimphos was
administered at dietary concentrations of 0.2, 0.7 or 5.0 ppm. The LOEL was
5.0 ppm based on plasma, erythrocyte, and brain cholinesterase inhibition.
The NOEL was 0.7 ppm. Rats were fed tebupirimphos for 2 years at dietary
concentrations of 1, 5 or 25 ppm. The LOEL was 5 ppm on the basis of
cholinesterase inhibition. The NOEL for systemic effects was 1 ppm. In a 6
month supplemental cholinesterase study using rats, 0.3 ppm was established as
a statistical NOEL for erythrocyte cholinesterase.
CARCINOGENICITY.......: Cyfluthrin was investigated for carcinogenicity in
chronic studies using several different strains of rats and mice. In rats,
the maximum level tested was 450 ppm. Maximum levels tested in mice were 1400
and 1600 ppm for males and females, respectively. There was no evidence of a
carcinogenic potential observed in any of the strains in either species.
Tebupirimphos was investigated for carcinogenicity in chronic studies using
mice and rats. There was no evidence of a carcinogenic potential of
tebupirimphos in either species.
MUTAGENICITY..........: CYFLUTHRIN: Numerous in vitro and in vivo mutagenicity
studies have been conducted on cyfluthrin, all of which are negative.
TEBUPIRIMPHOS: Numerous in vitro and in vivo mutagenicity studies have been
conducted on tebupirimphos, all of which are negative.
DEVELOPMENTAL TOXICITY: CYFLUTHRIN: In a developmental toxicity study using
rats, cyfluthrin was administered during gestation by oral gavage at doses
ranging from 1 to 30 mg/kg. The overall NOEL from these studies for maternal
toxicity was 3 mg/kg. No developmental effects were observed at any of the
doses tested. In each study the NOEL for developmental toxicity was
equivalent to the highest dose tested. The NOELs for developmental toxicity
for the initial study and the subsequent study were 30 and 10 mg/kg,
respectively. Rabbits were administered cyfluthrin during gestation by oral
gavage at doses ranging from 5 to 180 mg/kg. At maternally toxic levels,
there was an increased incidence of post-implantation losses. The overall
NOEL derived from these studies for both maternal and developmental toxicity
was 20 mg/kg. In an inhalation study, rats were exposed during gestation to
cyfluthrin at aerosol concentrations of 0.46, 2.55 or 11.9 mg/m3 for 6
hours/day. NOELs for maternal and developmental toxicity were less than 0.46
and 0.46 mg/m3, respectively. TEBUPIRIMPHOS: In a teratology study using
rats, tebupirimphos was administered orally at doses of 0.25, 0.5 and 0.75
mg/kg. Fetotoxic and teratogenic effects were not observed at any dose. The
maternal NOEL was 0.5 mg/kg. When tebupirimphos was tested using rabbits at
oral doses of 0.03, 0.1 and 0.3 mg/kg, there was an increased incidence of
resorptions at the maternally toxic level of 0.3 mg/kg. Teratogenic effects
were not observed at any dose. The NOEL for both embryo- and maternal
Product Code: 11612 MSDS Page 7
Approval date: 03/06/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
toxicity was 0.1 mg/kg.
REPRODUCTION..........: CYFLUTHRIN: In a reproduction study, cyfluthrin was
administered to rats for 3 generations at dietary concentrations of 50, 150
and 450 ppm. Reproductive effects observed at parentally toxic levels
included reductions in viability, lactation, litter size, feed consumption,
and pup birth weights and body weight gains. Coarse tremors were observed in
some offspring at 450 ppm. The NOEL for both parental and reproductive
effects was 50 ppm. In another reproduction study, cyfluthrin was
administered to rat s for 2 generations at dietary concentrations of 50, 125
or 400 ppm. Coarse tremors occurring in conjunction with parental toxicity
were observed in the offspring in the mid- and high-dose groups. Based on
this finding, the neonatal NOEL was 50 ppm. The NOELs for parental and
reproductive toxicity were 50 and 400 ppm, respectively. TEBUPIRIMPHOS:
Tebupirimphos was investigated in a 2 generation reproductive study in rats at
dietary concentrations of 1, 5 and 25 ppm. Reproductive effects occurred at
the maternally toxic level of 25 ppm. These effects included decreased
fertility rates in adults and cholinesterase inhibition, behavorial changes
and decreased growth and survival rates in the offspring. The reproductive
NOEL was 5 ppm.
NEUROTOXICITY ........: CYFLUTHRIN: Numerous neurotoxicity studies have been
conducted on cyfluthrin. Oral gavage studies using hens, have indicated that
at extremely high dose levels (5000 mg/kg), minimal nerve damage occurs. When
rats were administered cyfluthrin daily at oral doses of 40 to 80 mg/kg for 14
days, minimal nerve effects were seen. These effects were completely
reversible within a 3 month recovery period. In dermal and inhalation studies
which are more relevant to field exposure, there was no evidence of delayed
neurotoxicity in hens. In a special investigative study, litters of neonatal
mice (10 days of age) and their mothers were exposed to aerosol concentrations
of 5, 15, or 50 mg/m3 for 6.3 hours/day for 7 successive days. Motor activity
was measured in the offspring at 4 months of age (approximataely 3.5 months
post-exposure). At 50 mg/m3, all of the offsprings died or were sacrificed in
a moribund state following the first exposure. Mortalities were not observed
at any of the other levels. Clinical symptoms were observed immediately after
exposure in young mice at 15 mg/m3, and included decreased motility, temporary
scratching, and tonic convulsions. There was an increase in motor activity in
mice at 15 mg/m3. Histopathological investigations did not reveal any
treatment-related findings in mice at the age of 4 months. TEBUPIRIMPHOS:
There was no evidence of a neurotoxic effect in antidote protected hens
treated by oral gavage ata 10 mg/kg with tebupirimphos. In an acute
neurotoxicity study using rats, tebupirimphos was administered as a single
oral dose at analtyically confirmed levels of 0.5, 2 or 5 mg/kg for males and
0.3, 0.5 and 1 mg/kg for females. All clinical signs and neurobehavioral
effects were ascribed to acute cholinergic toxicity, occurring at dose levels
that produced substantial inhibition of cholinesterase activity, and with
complete recovery in surviving animals within 14 days following treatment.
Excluding cholinergic responses, the NOEL for neurotoxicity is 5 mg/kg for
males and 1 mg/kg for females (the highest dose tested). In a 13 week
neurotoxicity study, tebupirimphos was administered to rats at dietary
concentrations of 4, 16 or 60 ppm for males and 4, 12 or 40 ppm for females.
All clinical signs and neurobehavioral effects observed were ascribed to
cholinergic toxicity, occurring at exposure levels that produced substantial
Product Code: 11612 MSDS Page 8
Approval date: 03/06/2003 Continued on next page
11. TOXICOLOGICAL INFORMATION (Continued)
-------------------------------------------
inhibition of cholinesterase activity. There were no correlative
micropathological findings within the neural tissues or skeletal muscle.
Excluding cholinergic responses, the NOEL for neurotoxicity was 60 ppm for
males and 40 ppm for females (high est doses tested).
-------------------------------------------------------------------------------
12. ECOLOGICAL INFORMATION:
-------------------------------------------------------------------------------
This product is toxic to fish and wildlife. Bayer CropScience will provide a
summary of specific data upon written request. As with any pesticide, this
product should be used according to label directions, and should be kept out of
streams, lakes and other aquatic habitats of concern. In event of a spill
emergency, call the emergency number on page 1.
-------------------------------------------------------------------------------
13. DISPOSAL CONSIDERATIONS
-------------------------------------------------------------------------------
WASTE DISPOSAL METHOD.......: Follow container label instructions for disposal
of wastes generated during use in compliance with the FIFRA product label.
In other situations, bury in an EPA approved landfill or burn in an
incinerator approved for pesticide destruction. Do not reuse container.
-------------------------------------------------------------------------------
14. TRANSPORTATION INFORMATION:
-------------------------------------------------------------------------------
TECHNICAL SHIPPING NAME........: Tebupirimphos & Cyfluthrin
FREIGHT CLASS BULK.............: Insecticide, NOI-NMFC 102100
FREIGHT CLASS PACKAGE..........: Insecticide, NOI-NMFC 102100
PRODUCT LABEL..................: Not Noted
DOT (DOMESTIC SURFACE)
----------------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticides, Solid, Toxic
HAZARD CLASS OR DIVISION ......: 6.1
UN/NA NUMBER...................: UN2783
PACKING GROUP .................: III
DOT PRODUCT RQ lbs (kgs).......: None
HAZARD LABEL(s)................: Toxic
HAZARD PLACARD(s)..............: Toxic
IMO / IMDG CODE (OCEAN)
-----------------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticides, Solid, Toxic
HAZARD CLASS DIVISION NUMBER...: 6.1
Product Code: 11612 MSDS Page 9
Approval date: 03/06/2003 Continued on next page
14. TRANSPORTATION INFORMATION (Continued)
--------------------------------------------
IMO / IMDG CODE (continued)
---------------------------
UN NUMBER......................: UN2783
PACKAGING GROUP................: III
HAZARD LABEL(s)................: Toxic
HAZARD PLACARD(s)..............: Toxic
ICAO / IATA (AIR)
-----------------
PROPER SHIPPING NAME...........: Organophosphorus Pesticides, Solid, Toxic
HAZARD CLASS DIVISION NUMBER...: 6.1
UN NUMBER......................: UN2783
SUBSIDIARY RISK................: None
PACKING GROUP..................: III
HAZARD LABEL(s)................: Toxic
RADIOACTIVE?...................: Non-Radioactive
-------------------------------------------------------------------------------
15. REGULATORY INFORMATION:
-------------------------------------------------------------------------------
OSHA STATUS.................: This product is hazardous under the criteria of
the Federal OSHA Hazard Communication Standard 29
CFR 1910.1200.
TSCA STATUS.................: This product is exempt from TSCA Regulation under
FIFRA Section 3 (2)(B)(ii) when used as a
pesticide.
CERCLA REPORTABLE QUANTITY..: No components listed.
SARA TITLE III:
SECTION 302 EXTREMELY
HAZARDOUS SUBSTANCES..: No components listed.
SECTION 311/312
HAZARD CATEGORIES.....: Immediate Health Hazard; Delayed Health Hazard
SECTION 313
TOXIC CHEMICALS.......: Cyfluthrin (0.1%) - CAS #68359-37-5
RCRA STATUS.................: If discarded in its purchased form, this product
would not be a hazardous waste either by listing
or by characteristic. However, under RCRA, it is
the responsibility of the product user to
determine at the time of disposal, whether a
material containing the product or derived from
the product should be classified as a hazardous
waste. (40 CFR 261.20-24)
-------------------------------------------------------------------------------
16. OTHER INFORMATION:
-------------------------------------------------------------------------------
NFPA 704M RATINGS: Health Flammability Reactivity Other
2 1 0
Product Code: 11612 MSDS Page 10
Approval date: 03/06/2003 Continued on next page
16. OTHER INFORMATION (Continued)
-----------------------------------
0=Insignificant 1=Slight 2=Moderate 3=High 4=Extreme
Bayer CropScience鈥檚 method of hazard communication is comprised of Product Labels
and Material Safety Data Sheets. NFPA ratings are provided by Bayer CropScience as
a customer service.
REASON FOR ISSUE..........: Revise address,telephone numbers,new EPA Req. No.,
Sections 4,7,12 and 16
PREPARAED BY..............: C. A. Sheehan
APPROVED BY...............: S. E. Earnest
TITLE.....................: Manager, Quality Systems Services
APPROVAL DATE.............: 03/06/2003
SUPERSEDES DATE...........: 08/22/2000
MSDS NUMBER...............: 39828
-------------------------------------------------------------------------------
This information is furnished without warranty, expressed or implied, except
that it is accurate to the best knowledge of Bayer CropScience. The data on
this sheet relates only to the specific material designated herein. Bayer
CropScience assumes no legal responsibility for use or reliance upon these
data.
-------------------------------------------------------------------------------
Product Code: 11612 MSDS Page 11
Approval date: 03/06/2003 Last page
|